According to Ardelyx's latest financial reports and stock price the company's current number of shares outstanding is 222,782,229. At the end of 2023 the company had 222,782,229 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.22 B | 15.77% |
2022 | 0.19 B | 66.95% |
2021 | 0.11 B | 26.68% |
2020 | 90.98 M | 30.31% |
2019 | 69.82 M | 12.42% |
2018 | 62.1 M | 30.68% |
2017 | 47.52 M | 5.77% |
2016 | 44.93 M | 73.1% |
2015 | 25.95 M | 40.52% |
2014 | 18.47 M | 38.43% |
2013 | 13.34 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | 1,734,076,358 | 678.37% | ๐บ๐ธ USA |
Amgen AMGN | 535,000,000 | 140.14% | ๐บ๐ธ USA |
Sanofi SNY | 2,507,200,000 | 1,025.40% | ๐ซ๐ท France |
AstraZeneca AZN | 3,098,000,000 | 1,290.60% | ๐ฌ๐ง UK |
OPKO Health
OPK | 751,506,257 | 237.33% | ๐บ๐ธ USA |